United States · FDA National Drug Code directory
Cyclobenzaprine Hydrochloride
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 76282-283_19cb705f-c529-4ad4-8eda-3a3fd48feca7
- Product NDC
- 76282-283
- Form
- TABLET
- Composition / generic term
- Cyclobenzaprine
- Labeler
- EXELAN PHARMACEUTICALS, INC.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20250410
- Source listing expiry
- 20261231
Source-listed ingredients
- CYCLOBENZAPRINE HYDROCHLORIDE — 10 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 1000 TABLET in 1 BOTTLE (76282-283-10) · 76282-283-10
- 180 TABLET in 1 BOTTLE (76282-283-18) · 76282-283-18
- 270 TABLET in 1 BOTTLE (76282-283-27) · 76282-283-27
- 30 TABLET in 1 BOTTLE (76282-283-30) · 76282-283-30
- 60 TABLET in 1 BOTTLE (76282-283-60) · 76282-283-60
- 90 TABLET in 1 BOTTLE (76282-283-90) · 76282-283-90
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →